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Abstract: 25 
Background: In the outpatient setting elastomeric pumps are useful for the continuous 26 
administration of antibiotics with time-dependent bacterial killing activity such as amoxicillin. 27 
Objective: To determine the amoxicillin degradation in elastomeric pumps, as well as the 28 
effectiveness of treatment by verifying plasma drug levels and clinical outcome of patients 29 
treated in this way. 30 
Methods: Elastomeric pumps were filled with 6 g and 4 g /240 ml of NaCl 0.9%. Degradation 31 
was measured in the pumps filled with 6 g of amoxicillin by drawing samples at 12 hour 32 
intervals when stored in the fridge for 48 hours and when worn around the waist for 24 hours. 33 
Subsequently 9 patients were treated with continuous infusions of 8 g or 12 g of amoxicillin 34 
per day. Plasma amoxicillin levels were measured on each visit to the OPAT unit. Clinical 35 
outcome was verified 3 months after the end of treatment. 36 
Results: Amoxicillin degradation in elastomeric pumps filled with 6 g of amoxicillin /240 ml 37 
of NaCl 0.9% reached 10% after 48 hours in the fridge and an additional 30% when worn 38 
around the waist for 24 hours. Despite this significant degradation, mean plasma drug levels 39 
achieved with 12 g of amoxicillin per day were 18.5 mg/L (95%CI 13.5-23.5), which is 40 
largely above the MIC of amoxicillin-sensitive bacteria. 9 patients treated for various 41 
infections for a median of 28 days were cured and had no unexpected adverse effects. 42 
Conclusion: Adequate plasma drug levels and favourable clinical outcome suggest that 43 
amoxicillin can be administered by continuous infusions using elastomeric pumps. This 44 
treatment modality does not fulfil formal requirements regarding pharmaceutical stability. 45 
Still the resulting safety impact in patients is probably limited. Therapeutic drug monitoring 46 
and a close clinical follow up are recommended if this route of administration is chosen.   47 
Introduction:  48 
In the setting of outpatient parenteral antibiotic therapy (OPAT), elastomeric pumps can be 49 
useful devices for the continuous administration of antibiotics with time-dependent bacterial 50 
killing activity. The continuous infusion with elastomeric pumps notably avoids the need for 51 
multiple daily interventions of healthcare workers at patient’s home or multiple visits of the 52 
patient to the OPAT unit.  53 
 54 
A limiting factor for the use of elastomeric pumps is the potential drug instability in these 55 
devices over the infusion period. Generally, an antibiotic degradation remaining below 10% 56 
of the initial concentration is considered acceptable even though this limit has been chosen 57 
mostly arbitrarily.1 Stability data of antibiotic solutions in elastomeric pumps has been mostly 58 
published by manufacturers of these devices and they usually report the maximal duration of 59 
the drug stability at 5°C (fridge) and 25°C tested under standardised laboratory conditions. 60 
However, in the real-world setting the antibiotic solutions are exposed to temperatures that 61 
can rise well above 25°C.2  62 
 63 
For amoxicillin, the published stability data is contradictory. A study published by Arlicott et 64 
al suggests a reasonable stability in elastomeric pumps from the manufacturer Baxter.3 Indeed 65 
this study indicates a drug degradation of less than 10% at concentrations of 20 and 40 g/L 66 
when exposed to temperatures of 20°C and 35°C for 24 hours. Toxikon Europe NV, Leuven, 67 
Belgium, which tested the stability of amoxicillin in the elastomeric pumps from the 68 
manufacturer B. Braun Medical, indicates however a stability at 25°C of only 4 and 2 hours at 69 
concentrations of 1g/L and 40 g/L, respectively, without giving any detailed data about their 70 
experiments.4 According to this source the stability of amoxicillin, when kept refrigerated, is 71 
6 hours. Although these experiments were conducted by using elastomeric pumps of different 72 
brands, there is no reason to expect such important differences between devices.  73 
 74 
In this study, we investigated if amoxicillin could be administered by elastomeric pumps by 1) 75 
evaluating the antibiotic degradation in these devices, 2) measuring the plasma drug levels 76 
and 3) verifying the clinical outcome of 9 patients treated.  77 
 78 
Methods 79 
Elastomeric pumps (Easypump LT-270-24®, B. Braun Medical Inc, Melsungen, Germany) 80 
were filled with amoxicillin 6 g or 4g/240 ml NaCl 0.9% without buffering agent by the 81 
pharmacy under sterile conditions using a laminar flow cabinet. The devices were stored for 82 
up to 48 hours in the fridge at 5°C.  83 
 84 
Before treating any patients, we measured, on three different occasions, the antibiotic 85 
degradation in elastomeric pumps filled with 6 g of amoxicillin/240 ml NaCl 0.9%, stored in 86 
the fridge for 48 hours and then carried by volunteers around the waist for 24 hours.  87 
 88 
Based on these results our pharmacokinetic calculations indicated that continuous infusions 89 
with elastomeric pumps would still achieve amoxicillin plasma levels above 4 mg/L despite 90 
the measured antibiotic degradation. The minimal inhibitory concentration for amoxicillin 91 
sensitive gram-positive cocci being 4 mg/L or less5, we considered that we would not put 92 
patients at risk of treatment failure. We therefore subsequently treated 9 patients with 93 
continuous amoxicillin administration by elastomeric pumps. 94 
 95 
Patients were provided with prepared elastomeric pumps, which they stored in their fridge at 96 
home. The pumps were either changed by the patients themselves, by home-based nurses or at 97 
the OPAT-unit. Amoxicillin plasma levels were drawn when patients visited the OPAT clinic 98 
for clinical follow-up, in principle every 7 days.  99 
 100 
The patients’ clinical outcome of was evaluated 3 months after the end of the treatment. 101 
Patients were considered cured if they had not been re-started on antibiotic treatment or re-102 
admitted to hospital for the same problem. This was verified by checking the electronic 103 
hospital records. Considering that these patients were all treated for serious infections, we 104 
considered that all patients with failing treatment would most probably be re-admitted.   105 
 106 
Results: 107 
After 48 hours storage in the fridge at 5°C the mean concentration decreased from 29.0 ± 0.9 108 
g/L to 26.4 ± 1.4 g/L (-9%). When the elastomeric pumps were carried by volunteers for 24 109 
hours, the antibiotic concentration decreased from a mean 26.4 ± 1.4 g/L to 18.0 ± 2.2 g/L (-110 
32%).  111 
 112 
Table 1 shows the demographic details, the pathologies, the micro-organisms responsible and 113 
the plasma drug levels for the 9 patients treated. All patients had normal renal functions with 114 
creatinine clearances > 60 ml/min and they were treated as outpatients for a median of 28 115 
days (range 7- 36 days).   116 
 117 
The results of the plasma drug levels are summarised in Figure 1. The continuous infusions of 118 
8 g and 12 g of amoxicillin provided mean plasma levels of 5.1 mg/L (95%CI 0.1 – 10.1) and 119 
18.5 mg/L (95%CI 13.5-23.5), respectively.  120 
 121 
None of the patient had any significant side-effects and all patients were considered cured 3 122 
months after the end of treatment. 123 
 124 
Discussion: 125 
Despite a significant drug degradation exceeding the legally tolerated limit of 10%, this data 126 
suggests that a continuous infusion of amoxicillin using elastomeric pumps can ensure 127 
efficacious concentration exposure. Our observations indicate that the mean plasma drug 128 
levels of 18.5 mg/L are overall sufficient in patients treated with 12 g per day of amoxicillin 129 
administered by a continuous infusion using elastomeric pumps. Caution should be exercised 130 
with patients on 8 g amoxicillin per day, as the mean plasma levels of 5.1 mg/L were only 131 
slightly above the target levels recommended for enterococci. In comparison amoxicillin has 132 
an average serum half-life of 1.2 hours and a rapid infusion of amoxicillin 2 grams results in 133 
plasma levels of 50.2 mg/L after 1 hour, 16.3 mg/L after 2 hours and 3.3 mg/L after 4 hours.  134 
 135 
There are several possible explanations for the low plasma levels of 0.9 mg/L and 2.4 mg/L 136 
found in 2 patients receiving the 12 gram dose. First there could have been a problem with the 137 
storage or the continuous flow of the antibiotic solution, but the patients didn’t report any 138 
such problem. Secondly, improper collection and delayed transport of the blood specimens 139 
before analysis could be a reason. Of note, plasma levels determined in these two same 140 
patients on 3 and 2 additional occasions showed mean concentrations of 12.2 mg/L and 27.0 141 
mg/L, respectively.    142 
 143 
Besides the plasma drug levels, the clinical data is also reassuring as all patients were cured 3 144 
months after the end of treatment, and no patient had any unexpected adverse effects. 145 
 146 
These results should be put in perspective with the current recommendations that antibiotic 147 
degradation should not exceed 10% of the nominal concentrations of the solution introduced 148 
into elastomeric devices. The legislation is certainly clear about this point, but on the other 149 
hand it is known that amoxicillin is mainly converted to penicilloic acid, also formed through 150 
in vivo degradation of amoxicillin and essentially devoid of toxicity (but probably involved in 151 
immuno-allergic reactions).  152 
 153 
In conclusion continuous infusion with elastomeric pumps, at suitable antibiotic doses, 154 
provided sustained amoxicillin levels well over the MIC of amoxicillin-sensitive bacterial 155 
micro-organisms, and was clinically efficacious. Future studies aiming at determining 156 
whether a given antibiotic can be administered using elastomeric pumps should certainly 157 
consider the drug’s physico-chemical stability in the elastomeric devices – assessed in real-158 
life conditions. Still, it is also important to take into account the potential pharmacokinetic 159 
impact in patients, in addition to thorough clinical follow up for safety and tolerability. To 160 
that endeavour, therapeutic drug monitoring is recommended for ascertaining antibiotic 161 
plasma exposure in patients receiving prolonged infusion via elastomeric pumps.  162 
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Table.  170 
Sex / 
age (y) Diagnosis 
Infecting 
bacteria 
MIC 
(mg/L) 
Duration of 
treatment 
(days) 
Type of 
support for 
administration 
Dose 
(grams) 
Drug 
level 1 
(mg/L) 
Drug 
level 2 
(mg/L) 
Drug 
level 3 
(mg/L) 
Drug 
level 4 
(mg/L) 
M/83 Prosthetic valve endocarditis E. faecalis 0.75 28 
Home-based 
nurses 12 31    
F/57 Prosthetic valve endocarditis E. faecalis NA 29 
Self-
administration 12 20.3 17.2 19  
M/35 Osteomyelitis + infection of hardware E. faecalis NA 31 
Self-
administration 12 18.1 10.7 8 0.9 
M/78 Prosthetic valve endocarditis E. faecalis NA 21 
Home-based 
nurses 12 2,4 24,9 29,1  
M/85 Native valve endocarditis E. faecalis 1.0 14 
Home-based 
nurses 12 34,1 20,1   
M/46 Native valve endocarditis 
Strep. 
mitis NA 28 
Self-
administration 12 22,7 19,2 22,9 17,2 
M/75 Native valve endocarditis E. faecalis NA 21 
Home-based 
nurses 12 20,4 17,2   
M/71 Febrile agranulocytosis E. faecalis NA 7 OPAT-unit 8 3    
F/66 Osteomyelitis + infection of hardware E. faecalis NA 36 
Self-
administration 8 7 5.3   
  171 
Figure 1. Amoxicillin plasma levels (mean ± SD) according to total daily dose of amoxicillin 172 
administered as continuous infusions with elastomeric pumps. 173 
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